Gene: SLC22A23
Official Full Name: solute carrier family 22 member 23provided by HGNC
Gene Summary: SLC22A23 belongs to a large family of transmembrane proteins that function as uniporters, symporters, and antiporters to transport organic ions across cell membranes (Jacobsson et al., 2007 [PubMed 17714910]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14077 | SLC22A23 Knockout cell line (HeLa) | Human | SLC22A23 | 1:3~1:6 | Negative | Online Inquiry |
KO14078 | SLC22A23 Knockout cell line (HCT 116) | Human | SLC22A23 | 1:2~1:4 | Negative | Online Inquiry |
KO14079 | SLC22A23 Knockout cell line (HEK293) | Human | SLC22A23 | 1:3~1:6 | Negative | Online Inquiry |
KO14080 | SLC22A23 Knockout cell line (A549) | Human | SLC22A23 | 1:3~1:4 | Negative | Online Inquiry |
SLC22A23 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically modified to lack the SLC22A23 gene, which encodes for a member of the solute carrier family of transporters. This gene is implicated in the transport of various organic molecules, making its knockout crucial for studying its functional roles in cellular physiology and pathology. These cell lines serve as valuable tools for elucidating the genetic and molecular mechanisms underlying diseases related to the transport of metabolites, neurotransmitters, and pharmaceuticals.
The primary function of SLC22A23 Gene Knockout Cell Lines is to enable researchers to investigate the effects of impaired carrier function on cellular processes, such as drug uptake, metabolism, and clearance. By utilizing the knockout model, scientists can observe alterations in signaling pathways and metabolic processes that depend on the activity of the SLC22A23 transporter, providing insights into its role in health and disease. This understanding is particularly significant in the context of drug discovery and development, where transport mechanisms often dictate the efficacy and toxicity of therapeutic agents.
In research and clinical applications, these cell lines offer distinct advantages over traditional wild-type models. As controllable models of gene function, they facilitate high-throughput screening assays and are instrumental in validating potential therapeutic targets. The specificity of the knockout allows for clearer interpretations of data regarding gene function and its implications in various biological contexts, thus providing critical insights that could lead to novel interventions.
Furthermore, the SLC22A23 Gene Knockout Cell Lines are beneficial for both academic and industrial researchers focusing on pharmacology, toxicology, and gene therapy. This makes them an indispensable resource for laboratories pursuing cutting-edge research in transporter biology.
Our company is dedicated to providing high-quality biological tools that empower the scientific community. With a commitment to innovation and excellence, we offer a range of products designed to support impactful research and drive significant advancements in the understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.